Dental Biomaterials Market Report 2025

The dental biomaterials market size has grown strongly in recent years. It will grow from $8.49 billion in 2024 to $9.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to emergence of CAD/CAM, advances in periodontal therapies, growth in endodontic treatments, evolution of dental adhesive, introduction of dental implants.

The dental biomaterials market size is expected to see strong growth in the next few years. It will grow to $12.71 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of digital dentistry, growing demand for aesthetic dentistry, rise in aging population and dental implant procedure, focus on minimally invasive procedure, demand for eco-friendly and biocompatible materials. Major trends in the forecast period include personalized dentistry and patient-specific solutions, sustainability and biocompatibility, demand for aesthetic and functional restorations, focus on regenerative dentistry.

The dental biomaterials market is poised for growth owing to the increasing prevalence of dental disorders globally. Dental biomaterials play a vital role in offering effective solutions for oral health issues by providing added protection, remineralization, and bioactive prevention. The World Health Organization reported that nearly 3.5 billion individuals worldwide suffer from oral disorders, emphasizing the widespread nature of dental issues. With permanent tooth decay being a prevalent ailment affecting billions, the demand for dental biomaterials is expected to surge, addressing the rising need for innovative solutions in oral healthcare.

The dental biomaterials market is expected to witness substantial growth due to the increasing number of dental clinics and practitioners. Dental clinics utilize biomaterials such as ceramics, polymers, and metals for restorative and cosmetic dentistry procedures. According to the American Dental Association (ADA) Health Policy Institute, the number of dentists per 100,000 people is anticipated to rise, reaching 67 dentists from 2025 to 2040. This surge in dental professionals indicates a growing demand for biomaterials in dental practices, contributing to the overall expansion of the dental biomaterials market.

Technological advancements represent a significant trend gaining traction in the dental biomaterials market. Leading companies in the market are concentrating on research and development to innovate products that provide additional benefits and enhance performance. These product innovations allow companies to achieve a competitive advantage. For example, in February 2023, Nobel Biocare, a Switzerland-based dental implants manufacturer, collaborated with Mimetis Biomaterials S.L., a Spain-based company specializing in bone regenerative solutions, to introduce the creos syntogain biomimetic bone graft substitute. This represents the latest generation of synthetic bone grafts, composed of 80% Calcium Deficient Hydroxyapatite (CDHA) and 20% β-TCP (beta-tricalcium phosphate). This composition closely mimics human bone, as the closer a material resembles human bone, the more effective it is for promoting bone formation.

Leading companies in the dental biomaterials market are introducing new products, such as growth factor-rich membranes, to expand their customer bases and boost revenue. A growth factor-rich membrane is a biomaterial that contains a concentrated mix of growth factors, cytokines, and other biological enhancers designed to facilitate optimal tissue regeneration and wound healing. For example, in October 2023, ZimVie, a US-based manufacturer of medical instruments, launched the Biotivity A/C Plus Membrane, a biomaterial rich in growth factors. This innovative membrane, sourced from human placental tissue, is notable in the market for its unique approach to dental procedures. Composed of growth factors, cytokines, chemokines, and hyaluronic acid, it enhances wound healing during jaw repair and reconstruction for dental implants. Importantly, the Biotivity A/C Plus Membrane undergoes minimal manipulation, preserving its natural properties, and is sterilized using the Excellion Process. Its antibiotic-free processing sets it apart from other A/C membranes available in the market.

In April 2023, Henry Schein Inc., a US-based provider of healthcare solutions for office-based dental and medical practitioners, acquired Biotech Dental S.A.S. for an undisclosed amount. This acquisition aims to establish a digital workflow that delivers a seamless experience for customers, improving case acceptance and enhancing clinical outcomes for practitioners. Biotech Dental S.A.S. is a French manufacturer of dental biomaterials.

Major companies operating in the dental biomaterials market are Straumann Group, Geistlich Biomaterials, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., 3M Company, Koninklijke DSM N.V., Kuraray Co Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Ivoclar Vivadent AG, Bego Medical GmbH, Institut Straumann AG, BioHorizons IPH Inc., Nobel Biocare Services AG, ACE Surgical Supply Company Inc., Biomatlante, Align Technology Inc., Carestream Dental LLC, Datum Dental Ltd., VITA Zahnfabrik H Rauter Gr KG, Coltene Whaledent AG, DMG Chemisch-Pharmazeutische Fabrik GmbH, Heraeus Kulzer GmbH, Kavo Dental GmbH, Septodont Holding, Ultradent Products Inc., VOCO GmbH.

North America was the largest region in the dental biomaterials market share in 2024. The regions covered in the dental biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dental biomaterials encompass biological and biosynthetic products employed in the treatment of tooth decay, damage, fractures, and the restoration of bones, soft tissues, and periodontal structures in the field of dentistry.

The primary types of dental biomaterials include metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials, and composite biomaterials. Metallic biomaterials find frequent application in joint replacements, dental implants, orthopedic fixations, and stents, providing internal support to biological tissues. Various types of bone graft materials, such as allograft, xenograft, and synthetic options, are utilized. These biomaterials are applied in orthodontics, implantology, prosthodontics, and other dental procedures. Dental biomaterials are commonly used in dental hospitals and clinics, dental laboratories, dental academies, research institutes, and dental product manufacturing.

The dental biomaterials market research report is one of a series of new reports that provides dental biomaterials market statistics, including the dental biomaterials industry’s global market size, regional shares, competitors with a dental biomaterials market share, detailed dental biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the dental biomaterials industry. This dental biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dental biomaterials market consists of sales of dental cement, membranes, and soft tissue regeneration products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.